(Q50502530)
Statements
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. (English)
1 reference
Kelly K Hunt
1 reference
Ana M Gonzalez-Angulo
1 reference
Gabriel N Hortobagyi
1 reference
Aman U Buzdar
1 reference
Catherine M Kelly
1 reference
Marjorie C Green
1 reference
Kristine Broglio
1 reference
Eva S Thomas
1 reference
Abenaa M Brewster
1 reference
Vicente Valero
1 reference
Nuhad K Ibrahim
1 reference
Daniel J Booser
1 reference
Ronald S Walters
1 reference
13 February 2012
1 reference
30
1 reference
9
1 reference
930-935
1 reference